Cargando…
Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling?
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1996
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074718/ https://www.ncbi.nlm.nih.gov/pubmed/8826873 |
| _version_ | 1782138026625859584 |
|---|---|
| author | David, L. |
| author_facet | David, L. |
| author_sort | David, L. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2074718 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1996 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-20747182009-09-10 Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling? David, L. Br J Cancer Letter Nature Publishing Group 1996-09 /pmc/articles/PMC2074718/ /pubmed/8826873 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter David, L. Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling? |
| title | Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling? |
| title_full | Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling? |
| title_fullStr | Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling? |
| title_full_unstemmed | Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling? |
| title_short | Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling? |
| title_sort | tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling? |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074718/ https://www.ncbi.nlm.nih.gov/pubmed/8826873 |
| work_keys_str_mv | AT davidl tenascinandoncofetalfibronectinoncofetalmarkersorindicatorsofextracellularmatrixremodelling |